Joint

Topical Magnesium is the Best Way to Get the Essential Mineral to Keep Your Body in Optimal Condition

Dietary supplement, USP, Sleep, Magnesium, Fatigue, Aloe vera, Inflammation, PALM, Vitamin D, Specialization, Immune system, Joint, Magnesium deficiency, Gel, Magnesium chloride, Risk, Osteoporosis, Relaxation, Magnesium oil, Skin, Cramp, GLOBE, Limestone, Salt, Explosive
Thursday, September 23, 2021 - 7:32pm

Beyond the enjoyment factor, topical application of magnesium is the best way to increase cellular magnesium levels.

Key Points: 
  • Beyond the enjoyment factor, topical application of magnesium is the best way to increase cellular magnesium levels.
  • The best way to get magnesium into your body is with topical application of quality magnesium oils, gels,and bath crystals.
  • Magnesium Gel: Less concentrated, Magnesium Gel provides the benefits of purified magnesium chloride formulated with seaweed extract for people with more sensitive skin.
  • We want them to know that topical magnesium application is the best way to meet theirnecessary magnesium requirements.

Global Viscosupplementation System Markets 2021-2027: Focus on Single-Injection, Three-Injection, and Five-Injection - ResearchAndMarkets.com

Surgery, Health, Medical Devices, Weight loss, Patient, Hip, Arthritis, Osteoarthritis, Joint, Growth, Geography, Awareness, Cartilage, Organic acid, Government, Industry, Pharmaceutical industry, Oil
Thursday, September 23, 2021 - 4:09pm

Furthermore, improved healthcare infrastructure and increased awareness about viscosupplementation are expected to provide significant growth to the global viscosupplementation market.

Key Points: 
  • Furthermore, improved healthcare infrastructure and increased awareness about viscosupplementation are expected to provide significant growth to the global viscosupplementation market.
  • On the other hand, the global viscosupplementation market is projected to hinder by stringent government regulations and increasing insurance denials for viscosupplementation products.
  • However, due to the treatment effectiveness in providing relief to patients, the market for viscosupplementation in knee osteoarthritis is rapidly increasing.
  • The global viscosupplementation market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World.

Cable and Accessories Market Size to Increase by $ 6.91 bn during 2020-2024 | 17000 + Technavio Reports

APAC, Sumitomo Corporation, Connected space, MEA, USD, Application, Geography, 3M, CAGR, Hubbell Incorporated, Joint, Growth, COVID-19, ABB, Competitive analysis, TE, Investment, Trelleborg (company), Trelleborg, Electrical wiring, Pet
Thursday, September 23, 2021 - 4:00am

The cable and accessories market value is anticipated to grow by $ 6.91 bn, progressing at a CAGR of over 3.47% during the forecast period.

Key Points: 
  • The cable and accessories market value is anticipated to grow by $ 6.91 bn, progressing at a CAGR of over 3.47% during the forecast period.
  • Factors such as the large-scale deployment of explosion-resistant cable terminations andthe evolution of high-temperature superconducting cables will be crucial in driving the growth of the cable and accessories market.
  • On the other hand, the faults in cable terminations and joints resulting in cable failure are expected to reduce the growth potential in the market.
  • The competitive scenario provided in the cable accessories market report analyzes, evaluates, and positions companies based on various performance indicators.

Axonics® Provides Additional Update on Inter Partes Review Proceedings

Biotechnology, Health, Medical Supplies, Medical Devices, United States Court of Appeals for the Federal Circuit, Patent, PTAB, Patent Trial and Appeal Board, Review, Overactive bladder, MRI, Solution, Security (finance), Douglas v. U.S. District Court ex rel Talk America, Private Securities Litigation Reform Act, Electric Bond and Share Company v. Securities and Exchange Commission, IPR, Patient, Inter partes review, List, SNM, District court, Woman, Urinary incontinence, Fecal incontinence, Joint, Intellectual property, Nasdaq, Medtronic, SUI, Central District, Pharmaceutical industry, Generic drug, Online gambling
Wednesday, September 22, 2021 - 11:08pm

In March 2020, Axonics filed petitions with the PTAB requesting inter partes review (IPR) to contest the validity of patents Medtronic has alleged to be infringed by Axonics.

Key Points: 
  • In March 2020, Axonics filed petitions with the PTAB requesting inter partes review (IPR) to contest the validity of patents Medtronic has alleged to be infringed by Axonics.
  • In September 2020, the PTAB granted Axonics request and instituted a review of the six Medtronic patents.
  • Today, the PTAB issued its decision on the three remaining Medtronic patents Axonics is contesting: Patent Nos.
  • Except as required by law, Axonics undertakes no obligation to update or revise any forward-looking statements to reflect new information, changed circumstances or unanticipated events.

Ontic Launches New Center of Excellence Led by Internationally Renowned Threat Assessment and Protective Intelligence Investigations Expert

Software as a service, Government, Protective intelligence, GSX, American National Standards Institute, Law enforcement, National standards, Joint, SIGMA, Violence, Hospital, Secret Service, Workplace violence, Georgetown University, Program, Center, Private sector, Fear, Leadership, Mental health, Risk, Homeland Security Centers of Excellence, Intelligence, Research, United States Department of Education, Randazzo, Safety, Organization, Education, Risk management
Wednesday, September 22, 2021 - 2:00pm

Recognized globally as an expert on targeted violence, threat assessment and protective intelligence investigations, Randazzo served a decade in the U.S. Secret Service and founded SIGMA Threat Management Associates, which was recently acquired by Ontic.

Key Points: 
  • Recognized globally as an expert on targeted violence, threat assessment and protective intelligence investigations, Randazzo served a decade in the U.S. Secret Service and founded SIGMA Threat Management Associates, which was recently acquired by Ontic.
  • "We are proud to launch the Ontic Center of Excellence with the leading edge threat assessment and protective intelligence investigative expertise of Dr. Marisa Randazzo," said Thomas Kopecky, Ontic chief strategy officer.
  • The Ontic Center for Excellence provides strategic consulting, program development, and training services in behavioral threat assessment, threat management, and violence prevention for safety and security professionals at major corporations, educational institutions and government agencies.
  • In addition to leading the Ontic Center of Excellence, Dr. Randazzo serves as director of threat assessment for Georgetown University.

Luckin Coffee Announces Launch of Scheme of Arrangement in Compliance with RSA

Debt-to-GDP ratio, Annual report, Compliance, Provisional liquidation, OTC, Houlihan Lokey, U.S. Securities and Exchange Commission, Coffee, Cayman, Note, Court, Harney Westwood & Riegels, Joint, Industry, GLOBE, Private Securities Litigation Reform Act, Company, Terminology, Growth, Hearing, RSA, Convening authority (court-martial), Forward-looking statement, Wardwell, Time, SEC, Security (finance)
Tuesday, September 21, 2021 - 12:35pm

Assuming the Scheme is approved by the requisite voting majorities at the Scheme Meeting, a further hearing to determine whether the Court will sanction the Scheme will take place.

Key Points: 
  • Assuming the Scheme is approved by the requisite voting majorities at the Scheme Meeting, a further hearing to determine whether the Court will sanction the Scheme will take place.
  • Copies of the petition and summons filed in respect of the Scheme are available on the scheme website at https://dm.epiq11.com/luckinscheme (the Scheme Website).
  • Luckin Coffee will publish a further announcement notifying the Scheme Creditors of the time and date of the Convening Hearing once confirmed by the Cayman Court.
  • Empowered by proprietary technologies, Luckin Coffee pursues its vision to build a world-class coffee brand and become a part of everyones daily life.

Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries

Vomiting, Food, Safety, Journal of Clinical Anesthesia, Pharmacokinetics, Vein, PK, Nervous system, Liver disease, Peri, Degenerative disease, Pain management, Molecule, Length of stay, Hospital, Constipation, FDA, Surgeon, Patient, Allergy, Population, MD, Adult, Nausea, Time-invariant system, Hydrogen chloride, Joint, Profile, Bupivacaine, Anesthetic, Food and Drug Administration, Ageing, Child, Pain, PLAY, Anesthesiology, Fasciculation, Fever, AES, Pregnancy, Nicklaus Children's Hospital, Spine, Time, Industry, Plasma, GLOBE, Dentistry, Mineral wool, Pharmaceutical industry
Tuesday, September 21, 2021 - 12:30pm

PARSIPPANY, N.J., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that full results of its Phase 3 PLAY study of EXPAREL (bupivacaine liposome injectable suspension) administered via infiltration in pediatric patients undergoing spinal or cardiac surgeries have been published in Journal of Clinical Anesthesia .

Key Points: 
  • PARSIPPANY, N.J., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that full results of its Phase 3 PLAY study of EXPAREL (bupivacaine liposome injectable suspension) administered via infiltration in pediatric patients undergoing spinal or cardiac surgeries have been published in Journal of Clinical Anesthesia .
  • There were no treatment-related cardiac or nervous system adverse events (AEs) in the EXPAREL arm.
  • Additionally, AEs were mild to moderate, supporting the safety of EXPAREL in pediatric patients undergoing spine or cardiac surgery.
  • Results of this study build upon a growing body of evidence supporting the use of EXPAREL in pediatric procedures.

JetBlue CEO Robin Hayes Provides an Update on the Northeast Alliance and Action by the U.S. Department of Justice (DOJ)

Legal, Labor, Air, Transport, Courts, Public Policy, Government, Professional Services, Transportation, Travel, Heathrow Airport, DOJ, JFK, American Airlines, Fortification, American Customer Satisfaction Index, Running, DOT, Aircraft, Customer, NEA, Fierce Five, Bluecity, LGA, NASDAQ, AAdvantage, Intention, Multimedia, U.S. Department of Justice Office of Legislative Affairs, Congress, JBLU, Senate, Airport, Growth, Love, COVID-19, Retirement, U.S. Department of Defense Strategy for Operating in Cyberspace, History, Joint, Foot, Investment, Industry, Silver, Travel, Airline, Taxicab
Tuesday, September 21, 2021 - 9:23pm

JetBlue (NASDAQ: JBLU) CEO Robin Hayes today issued the following message to the airlines 20,000 crewmembers:

Key Points: 
  • JetBlue (NASDAQ: JBLU) CEO Robin Hayes today issued the following message to the airlines 20,000 crewmembers:
    This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210921006083/en/
    Our Alliance with American Airlines means more flying for JetBlue.
  • Given our focus on the NEA, I wanted to talk about action the U.S. Department of Justice (DOJ) is taking in federal court to unwind the NEA.
  • JetBlue is New York's Hometown Airline, and a leading carrier in Boston, Fort Lauderdale-Hollywood, Los Angeles, Orlando and San Juan.

Theramex launches Bijuva® / Bijuve® (estradiol and progesterone), the first and only body-identical combined hormone therapy treatment for post-menopausal women*

Health, Pharmaceutical, Thrombosis, Estradiol, News, Sleep, Flash, Greendale, Quality of life (healthcare), Degenerative disease, Coagulation, Personal lubricant, JAMA, Somnolence, Solution, Progesterone, Hormone, Health, III, Vaginal discharge, FDA, Patient, Headache, HRT, Menopause, INT, Birth, Breast cancer, VMS, Joint, Woman, Awareness, Fertility, Sleep deprivation, Risk, NICE, Vaginal bleeding, Breast, National Institute, Osteoporosis, North American Menopause Society, Uterus, Quality of life, National Institute for Health and Care Excellence, EMA, Muscle, Birth control, Medical device, Wood drying
Tuesday, September 21, 2021 - 12:45pm

Theramex has today launched Bijuva / Bijuve (1mg estradiol / 100mg progesterone) across Europe and the UK.

Key Points: 
  • Theramex has today launched Bijuva / Bijuve (1mg estradiol / 100mg progesterone) across Europe and the UK.
  • Theramex CEO, Robert Stewart, commented, For many years menopausal women and their healthcare providers have been seeking an EMA approved body-identical combination therapy.
  • The approval of Bijuva / Bijuve during Menopause Awareness month represents an important new opportunity for menopausal women suffering from moderate to severe vasomotor symptoms.
  • Our commitment is to listen and understand our patients, serve their needs, and offer healthcare solutions to help improve their lives.

SKYMINT Acquires 3Fifteen Cannabis and Completes Concurrent $78 Million Financing From SunStream Bancorp and Merida Capital, Solidifying its Position as Michigan's top Cannabis Cultivator, Manufacturer, Retailer, and Employer

Zero, People, Hand, Plant, Music, The Rise and Fall of American Growth, Happy People, Domination, Culture, Population, Campaign Zero, Adult, Lansing–East Lansing metropolitan area, Senior, CEO, ANN, Acquisition, Freedom, Company, Life, No, Growth, Farm, Cass Community Social Services, Michigander, General counsel, Headset, Joint, Drug
Tuesday, September 21, 2021 - 3:44pm

SKYMINT's newly expanded retail presence of 27 locations gives the Company the largest cannabis retail footprint across Michigan.

Key Points: 
  • SKYMINT's newly expanded retail presence of 27 locations gives the Company the largest cannabis retail footprint across Michigan.
  • "SKYMINT was founded on a mission to become a leader in the cannabis industry while leveraging our leadership position as a positive catalyst for change," said SKYMINT CEO and co-founder Jeff Radway.
  • "SKYMINT is an award-winning company known for its retail presence, its vast manufacturing and cultivation capabilities, and a community-minded attitude.
  • Since its inception in 2018, SKYMINT has donated more than $500k to community organizations and nonprofits in and around Michigan.